FRAMINGHAM, Mass.--(BUSINESS WIRE)--Scientists at ETH Zurich and AB SCIEX, a global leader in life science analytical technologies, are working together to deliver a new mass spectrometry-based technique for scientists to get quantitation for the first time ever on every peptide in a single proteomics sample analysis. SWATH™ Acquisition is a breakthrough for proteomics mass spectrometry users to conduct comprehensive quantitation on the entire proteome. As a next step in its MRMAtlas collaboration with ETH Zurich’s Dr. Ruedi Aebersold, AB SCIEX is developing enhanced MS/MSALL functionality to enable SWATH™ Acquisition on the AB SCIEX TripleTOF™ 5600 System for scientists to utilize around the world. Details about SWATH™ Acquisition will be presented this week at the American Society of Mass Spectrometry (ASMS) conference in Denver.
